This report provides a summary of Cyclacel Pharmaceuticals Inc.'s product pipeline as of the second quarter of 2011. It details the company's focus on developing treatments for cancer and inflammatory diseases. The pipeline includes several drugs in clinical trials, including sapacitabine for blood cancers. The report is based on information from Cyclacel as well as third party sources, and provides profiles of pipeline drugs with details on development status and mechanisms of action. It is intended to help evaluate Cyclacel's strategic position and identify partnership or licensing opportunities.
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Cyclacel Pharmaceuticals Pipeline Review Q2 2011
1. Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – Q2 2011
Report Summary
Global Market Direct’s pharmaceuticals report, “Cyclacel Pharmaceuticals Inc. - Product
Pipeline Review - Q2 2011” provides data on the Cyclacel Pharmaceuticals Inc.’s research
and development focus. The report includes information on current developmental pipeline,
complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Cyclacel Pharmaceuticals Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Cyclacel Pharmaceuticals Inc.
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
• Cyclacel Pharmaceuticals Inc. - Brief Cyclacel Pharmaceuticals Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
• Review of current pipeline of Cyclacel Pharmaceuticals Inc. human therapeutic division.
• Overview of pipeline therapeutics across various therapy areas.
• Coverage of current pipeline molecules in various stages of drug development, including
the combination treatment modalities, across the globe.
• Product profiles for late stage and clinical stage products of Cyclacel Pharmaceuticals Inc.
with complete description of the product’s developmental history, mechanism of action,
therapeutic class, target and major milestones.
• Recent updates of the Cyclacel Pharmaceuticals Inc.’s market pipeline in the last quarter.
• Key discontinued and dormant projects.
• Latest news and deals relating to the products.
Browse All Pharmaceuticals Market Research Reports
Reasons to buy
• Evaluate Cyclacel Pharmaceuticals Inc.’s strategic position with total access to detailed
information on its product pipeline.
• Assess the growth potential of Cyclacel Pharmaceuticals Inc. in its therapy areas of focus.
• Identify new drug targets and therapeutic classes in the Cyclacel Pharmaceuticals Inc.’s
R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio
gaps.
• Exploit collaboration and partnership opportunities with Cyclacel Pharmaceuticals Inc..
• Avoid Intellectual Property Rights related issues.
• Explore the dormant and discontinued projects of Cyclacel Pharmaceuticals Inc. and
identify potential opportunities in those areas.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Cyclacel Pharmaceuticals Inc. Snapshot 5
2. Cyclacel Pharmaceuticals Inc. Overview 5
Key Information 5
Key Facts 5
Cyclacel Pharmaceuticals Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Cyclacel Pharmaceuticals Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Cyclacel Pharmaceuticals Inc. – Pipeline Products Glance 12
Cyclacel Pharmaceuticals Inc. – Late Stage Pipeline 12
Phase III Products/Combination Treatment Modalities 12
Cyclacel Pharmaceuticals Inc. Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Cyclacel Pharmaceuticals Inc.–Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Cyclacel Pharmaceuticals Inc. – Drug Profiles 17
Sapacitabine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Sapacitabine + Decitabine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Sapacitabine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Seliciclib 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Cell Cycle Inhibitors Program 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
CYC116 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Sapacitabine + Seliciclib 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CDK Inhibitors Program 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
3. CYC065 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
GSK-3 Inhibitors Program 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
PLK1 Inhibitor Program 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
GSK-3 Inhibitors Program 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Cyclacel Pharmaceuticals Inc. – Pipeline Analysis 31
Cyclacel Pharmaceuticals Inc. – Pipeline Products by Therapeutic Class 31
Cyclacel Pharmaceuticals Inc. - Pipeline Products By Target 33
Cyclacel Pharmaceuticals Inc. – Pipeline Products by Route of Administration 34
Cyclacel Pharmaceuticals Inc. – Pipeline Products by Molecule Type 35
Cyclacel Pharmaceuticals Inc. – Recent Pipeline Updates 36
Cyclacel Pharmaceuticals Inc. - Dormant Projects 39
Cyclacel Pharmaceuticals Inc. - Discontinued Pipeline Products 40
Discontinued Pipeline Product Profiles 40
Cell Cycle Inhibitors Program 40
Cyclin Binding Groove Inhibitors 41
Hdm2 Inhibitor Program 41
Cyclacel Pharmaceuticals Inc. – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 44
Contact Us 44
Disclaimer 44
List of Tables
Cyclacel Pharmaceuticals Inc. - Pipeline by Therapy Area and Indication, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline by Stage of Development, 2011
Cyclacel Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2011
Cyclacel Pharmaceuticals Inc. - Combination Treatment Modalities in Pipeline, 2011
Cyclacel Pharmaceuticals Inc. - Phase III, 2011
Cyclacel Pharmaceuticals Inc. - Phase II, 2011
Cyclacel Pharmaceuticals Inc. - Phase I, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Target, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Route of Administration, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Molecule Type, 2011
4. Cyclacel Pharmaceuticals Inc. - Recent Pipeline Updates, 2011
Cyclacel Pharmaceuticals Inc. - Dormant Developmental Projects, 2010
Cyclacel Pharmaceuticals Inc. - Discontinued Pipeline Products, 2010
Cyclacel Pharmaceuticals Inc., Other Locations
Cyclacel Pharmaceuticals Inc., Subsidiaries
List of Figures
Cyclacel Pharmaceuticals Inc. - Pipeline by Therapy Area and Indication, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline by Stage of Development, 2011
Cyclacel Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2011
Cyclacel Pharmaceuticals Inc. - Combination Treatment Modalities in Pipeline, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Target, 2011
Cyclacel Pharmaceuticals Inc. - Pipeline By Molecule Type, 2011
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Pagehttp://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
http://www.reportsnreports.com
Visit our Market Research Blog